Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate-Reference-Cited by-同舟云学术

Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate

Published:2017-03-21 Issue:1 Volume:7 Page:
ISSN:1869-5760
Container-title:Journal of Ophthalmic Inflammation and Infection
language:en
Short-container-title:J Ophthal Inflamm Infect

Author:

Mercado-Sesma Arieh^ORCID,Contreras-Rubio Angélica,Baiza-Durán Leopoldo,Olvera-Montaño Oscar,Miranda-Robles Mónica,Bonilla-García José

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1186/s12348-017-0127-2.pdf

Reference16 articles.

1. Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879–889

2. Mochizuki M (2010) Regional immunity of the eye. Acta Ophthalmol 88:292–299

3. El-Harazi SM, Feldman RM (2001) Control of intraocular inflammation associated with cataract surgery. Opin Ophthalmol 12:4–8

4. Dennis EA, Norris PC (2015) Eicosanoid storm in infection and inflammation. Nat Rev 15:511–523

5. Huang JJ, Gaudio PA (eds) (2010) Ocular inflammatory disease and uveitis manual. Diagnosis and treatment. Wolters Kluwer. Lippincott Williams & Wilkins, Baltimore

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPLC-UV Method Development and Validation to Monitor Difluprednate Synthesis;Journal of Chromatographic Science;2023-01-09

2. Therapeutic Efficacy of Difluprednate 0.05% Versus Prednisolone Acetate 1% in Controlling Inflammation and Macular Oedema Following Phacoemulsification: An Optical Coherence Tomography-Based Study;Cureus;2021-04-25

3. Emulsions for Topical Eye Delivery: State of the Art and Future Perspectives;Ophthalmic Product Development;2021

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

;Clinical Ophthalmology;2020-06